Mesirow Financial Investment Management, Inc. Omeros Corp Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 09, 2020	SELL	$9.03 - $19.72 $206,227 - $450,365	-22,838 Closed	0 $0
Q4 2019 Jan 09, 2020	SELL	$13.01 - $17.15 $9,913 - $13,068	-762 Reduced 3.23%	22,838 $322,000
Q3 2019 Oct 30, 2019	SELL	$14.55 - $20.56 $21,708 - $30,675	-1,492 Reduced 5.95%	23,600 $385,000
Q2 2019 Jul 12, 2019	BUY	$15.0 - $19.62 $40,470 - $52,934	2,698 Added 12.05%	25,092 $374,000
Q1 2019 Apr 09, 2019	BUY	$11.65 - $17.72 $83,507 - $127,016	7,168 Added 47.08%	22,394 $389,000
Q3 2018 Oct 09, 2018	SELL	$17.73 - $26.69 $141,769 - $213,413	-7,996 Reduced 34.43%	15,226 $372,000
Q2 2018 Jul 11, 2018	BUY	$10.79 - $24.44 $250,565 - $567,545	23,222 New	23,222 $421,000
Q1 2018 Apr 17, 2018	SELL	$9.0 - $20.16 $169,272 - $379,169	-18,808 Closed	0 $0
Q4 2017 Jan 16, 2018	BUY	$13.26 - $22.86 $65,504 - $112,928	4,940 Added 35.62%	18,808 $365,000
Q3 2017 Oct 12, 2017	SELL	$19.76 - $24.9 $178,472 - $224,896	-9,032 Reduced 39.44%	13,868 $300,000
Q2 2017 Aug 17, 2017	BUY	N/A	22,900	22,900 $456,000

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

Ingalls & Snyder LLC New York, NY

4.54M
Shares

$55.2 Million
0.7% of portfolio
Black Rock Inc. New York, NY

4.1M
Shares

$49.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.26M
Shares

$39.6 Million
0.0% of portfolio
Stifel Financial Corp St. Louis, MO

1.9M
Shares

$23.1 Million
0.01% of portfolio
D. E. Shaw & Co., Inc. New York, NY

1.61M
Shares

$19.5 Million
0.01% of portfolio

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account